Phase II Study of FOLFOX With Bevacizumab (Avastin(TM)) in Metastatic or Unresectable Gastroesophageal and Gastric Cancer.
Phase of Trial: Phase II
Latest Information Update: 06 Feb 2015
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 03 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Jul 2014 Planned End Date changed from 1 Jul 2013 to 1 Jul 2014 according to ClinicalTrials.gov record.
- 12 Jul 2014 Planned primary completion date changed from 1 Jul 2013 to 1 May 2013 according to ClinicalTrials.gov record.